APO Research
Talk to an analyst

APO RESEARCH · REPORT

IBS-C Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global IBS-C Drug Market Analysis and Forecast 2026-2032

20 December 2025193 pages

Choose your research edition.

Industry ResearchIBS-C Drug Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal IBS-C Drug Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal IBS-C Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IBS-C Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal IBS-C Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global IBS-C Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for IBS-C Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for IBS-C Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for IBS-C Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for IBS-C Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of IBS-C Drug include Nestle, Synergy Pharmaceuticals, Catalent Pharmaceuticals Solutions and Abbott Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for IBS-C Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of IBS-C Drug, also provides the sales of main regions and countries. Of the upcoming market potential for IBS-C Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the IBS-C Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global IBS-C Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for IBS-C Drug sales, projected growth trends, production technology, application and end-user industry.

IBS-C Drug Segment by Company

Nestle

Synergy Pharmaceuticals

Catalent Pharmaceuticals Solutions

Abbott Laboratories

IBS-C Drug Segment by Type

LINZESS (Linaclotide)

Amitiza

Milk of Magnesia

Lactulose

Others

IBS-C Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

IBS-C Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IBS-C Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IBS-C Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IBS-C Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of IBS-C Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of IBS-C Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, IBS-C Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global IBS-C Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. LINZESS (Linaclotide) Major Manufacturers Table 3. Amitiza Major Manufacturers Table 4. Milk of Magnesia Major Manufacturers Table 5. Lactulose Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global IBS-C Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Retail Pharmacies Major Manufacturers Table 9. Online Pharmacies Major Manufacturers Table 10. Hospital Pharmacies Major Manufacturers Table 11. IBS-C Drug Industry Trends Table 12. IBS-C Drug Industry Drivers Table 13. IBS-C Drug Industry Opportunities and Challenges Table 14. IBS-C Drug Industry Restraints Table 15. Global IBS-C Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global IBS-C Drug Revenue by Region (2021-2026) & (US$ Million) Table 17. Global IBS-C Drug Revenue by Region (2027-2032) & (US$ Million) Table 18. Global IBS-C Drug Revenue Market Share by Region (2021-2026) Table 19. Global IBS-C Drug Revenue Market Share by Region (2027-2032) Table 20. Global IBS-C Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global IBS-C Drug Sales by Region (2021-2026) & (K Units) Table 22. Global IBS-C Drug Sales by Region (2027-2032) & (K Units) Table 23. Global IBS-C Drug Sales Market Share by Region (2021-2026) Table 24. Global IBS-C Drug Sales Market Share by Region (2027-2032) Table 25. Global IBS-C Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global IBS-C Drug Revenue Market Share by Manufacturers (2021-2026) Table 27. Global IBS-C Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global IBS-C Drug Sales Market Share by Manufacturers (2021-2026) Table 29. Global IBS-C Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global IBS-C Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global IBS-C Drug Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global IBS-C Drug Manufacturers, Product Type & Application Table 33. Global IBS-C Drug Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global IBS-C Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global IBS-C Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global IBS-C Drug Revenue by Type (2021-2026) & (US$ Million) Table 38. Global IBS-C Drug Revenue by Type (2027-2032) & (US$ Million) Table 39. Global IBS-C Drug Revenue Market Share by Type (2021-2026) Table 40. Global IBS-C Drug Revenue Market Share by Type (2027-2032) Table 41. Global IBS-C Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global IBS-C Drug Sales by Type (2021-2026) & (K Units) Table 43. Global IBS-C Drug Sales by Type (2027-2032) & (K Units) Table 44. Global IBS-C Drug Sales Market Share by Type (2021-2026) Table 45. Global IBS-C Drug Sales Market Share by Type (2027-2032) Table 46. Global IBS-C Drug Price by Type (2021-2026) & (US$/Unit) Table 47. Global IBS-C Drug Price by Type (2027-2032) & (US$/Unit) Table 48. Global IBS-C Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global IBS-C Drug Revenue by Application (2021-2026) & (US$ Million) Table 50. Global IBS-C Drug Revenue by Application (2027-2032) & (US$ Million) Table 51. Global IBS-C Drug Revenue Market Share by Application (2021-2026) Table 52. Global IBS-C Drug Revenue Market Share by Application (2027-2032) Table 53. Global IBS-C Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global IBS-C Drug Sales by Application (2021-2026) & (K Units) Table 55. Global IBS-C Drug Sales by Application (2027-2032) & (K Units) Table 56. Global IBS-C Drug Sales Market Share by Application (2021-2026) Table 57. Global IBS-C Drug Sales Market Share by Application (2027-2032) Table 58. Global IBS-C Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global IBS-C Drug Price by Application (2027-2032) & (US$/Unit) Table 60. Nestle Company Information Table 61. Nestle Business Overview Table 62. Nestle IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Nestle IBS-C Drug Product Portfolio Table 64. Nestle Recent Development Table 65. Synergy Pharmaceuticals Company Information Table 66. Synergy Pharmaceuticals Business Overview Table 67. Synergy Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Synergy Pharmaceuticals IBS-C Drug Product Portfolio Table 69. Synergy Pharmaceuticals Recent Development Table 70. Catalent Pharmaceuticals Solutions Company Information Table 71. Catalent Pharmaceuticals Solutions Business Overview Table 72. Catalent Pharmaceuticals Solutions IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Catalent Pharmaceuticals Solutions IBS-C Drug Product Portfolio Table 74. Catalent Pharmaceuticals Solutions Recent Development Table 75. Abbott Laboratories Company Information Table 76. Abbott Laboratories Business Overview Table 77. Abbott Laboratories IBS-C Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Abbott Laboratories IBS-C Drug Product Portfolio Table 79. Abbott Laboratories Recent Development Table 80. North America IBS-C Drug Revenue by Type (2021-2026) & (US$ Million) Table 81. North America IBS-C Drug Revenue by Type (2027-2032) & (US$ Million) Table 82. North America IBS-C Drug Sales by Type (2021-2026) & (K Units) Table 83. North America IBS-C Drug Sales by Type (2027-2032) & (K Units) Table 84. North America IBS-C Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 85. North America IBS-C Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 86. North America IBS-C Drug Revenue by Application (2021-2026) & (US$ Million) Table 87. North America IBS-C Drug Revenue by Application (2027-2032) & (US$ Million) Table 88. North America IBS-C Drug Sales by Application (2021-2026) & (K Units) Table 89. North America IBS-C Drug Sales by Application (2027-2032) & (K Units) Table 90. North America IBS-C Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 91. North America IBS-C Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 92. North America IBS-C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. North America IBS-C Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 94. North America IBS-C Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 95. North America IBS-C Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 96. North America IBS-C Drug Sales by Country (2021-2026) & (K Units) Table 97. North America IBS-C Drug Sales by Country (2027-2032) & (K Units) Table 98. North America IBS-C Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 99. North America IBS-C Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 100. United States IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 101. Canada IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 102. Europe IBS-C Drug Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe IBS-C Drug Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe IBS-C Drug Sales by Type (2021-2026) & (K Units) Table 105. Europe IBS-C Drug Sales by Type (2027-2032) & (K Units) Table 106. Europe IBS-C Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 107. Europe IBS-C Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 108. Europe IBS-C Drug Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe IBS-C Drug Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe IBS-C Drug Sales by Application (2021-2026) & (K Units) Table 111. Europe IBS-C Drug Sales by Application (2027-2032) & (K Units) Table 112. Europe IBS-C Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 113. Europe IBS-C Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 114. Europe IBS-C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe IBS-C Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. Europe IBS-C Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. Europe IBS-C Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 118. Europe IBS-C Drug Sales by Country (2021-2026) & (K Units) Table 119. Europe IBS-C Drug Sales by Country (2027-2032) & (K Units) Table 120. Europe IBS-C Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 121. Europe IBS-C Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 122. Germany IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 123. France IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 124. U.K. IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 125. Italy IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 126. Netherlands IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 127. China IBS-C Drug Revenue by Type (2021-2026) & (US$ Million) Table 128. China IBS-C Drug Revenue by Type (2027-2032) & (US$ Million) Table 129. China IBS-C Drug Sales by Type (2021-2026) & (K Units) Table 130. China IBS-C Drug Sales by Type (2027-2032) & (K Units) Table 131. China IBS-C Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 132. China IBS-C Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 133. China IBS-C Drug Revenue by Application (2021-2026) & (US$ Million) Table 134. China IBS-C Drug Revenue by Application (2027-2032) & (US$ Million) Table 135. China IBS-C Drug Sales by Application (2021-2026) & (K Units) Table 136. China IBS-C Drug Sales by Application (2027-2032) & (K Units) Table 137. China IBS-C Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 138. China IBS-C Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 139. Asia IBS-C Drug Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia IBS-C Drug Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia IBS-C Drug Sales by Type (2021-2026) & (K Units) Table 142. Asia IBS-C Drug Sales by Type (2027-2032) & (K Units) Table 143. Asia IBS-C Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 144. Asia IBS-C Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 145. Asia IBS-C Drug Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia IBS-C Drug Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia IBS-C Drug Sales by Application (2021-2026) & (K Units) Table 148. Asia IBS-C Drug Sales by Application (2027-2032) & (K Units) Table 149. Asia IBS-C Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 150. Asia IBS-C Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 151. Asia IBS-C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia IBS-C Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Asia IBS-C Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Asia IBS-C Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 155. Asia IBS-C Drug Sales by Country (2021-2026) & (K Units) Table 156. Asia IBS-C Drug Sales by Country (2027-2032) & (K Units) Table 157. Asia IBS-C Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 158. Asia IBS-C Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 159. Japan IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 160. South Korea IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 161. India IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 162. Australia IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 163. China Taiwan IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 164. Southeast Asia IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 165. SAMEA IBS-C Drug Revenue by Type (2021-2026) & (US$ Million) Table 166. SAMEA IBS-C Drug Revenue by Type (2027-2032) & (US$ Million) Table 167. SAMEA IBS-C Drug Sales by Type (2021-2026) & (K Units) Table 168. SAMEA IBS-C Drug Sales by Type (2027-2032) & (K Units) Table 169. SAMEA IBS-C Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 170. SAMEA IBS-C Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 171. SAMEA IBS-C Drug Revenue by Application (2021-2026) & (US$ Million) Table 172. SAMEA IBS-C Drug Revenue by Application (2027-2032) & (US$ Million) Table 173. SAMEA IBS-C Drug Sales by Application (2021-2026) & (K Units) Table 174. SAMEA IBS-C Drug Sales by Application (2027-2032) & (K Units) Table 175. SAMEA IBS-C Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 176. SAMEA IBS-C Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 177. SAMEA IBS-C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. SAMEA IBS-C Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. SAMEA IBS-C Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. SAMEA IBS-C Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 181. SAMEA IBS-C Drug Sales by Country (2021-2026) & (K Units) Table 182. SAMEA IBS-C Drug Sales by Country (2027-2032) & (K Units) Table 183. SAMEA IBS-C Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 184. SAMEA IBS-C Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Brazil IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 186. Argentina IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 187. Chile IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 188. Colombia IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 189. Peru IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 190. Saudi Arabia IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 191. Israel IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 192. UAE IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 193. Turkey IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 194. Iran IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 195. Egypt IBS-C Drug Revenue (2021-2032) & (US$ Million) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. IBS-C Drug Distributors List Table 199. IBS-C Drug Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. IBS-C Drug Image Figure 2. Global IBS-C Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IBS-C Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. LINZESS (Linaclotide) Image Figure 5. Amitiza Image Figure 6. Milk of Magnesia Image Figure 7. Lactulose Image Figure 8. Others Image Figure 9. Global IBS-C Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global IBS-C Drug Market Size Share 2021 VS 2025 VS 2032 Figure 11. Retail Pharmacies Image Figure 12. Online Pharmacies Image Figure 13. Hospital Pharmacies Image Figure 14. Global IBS-C Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global IBS-C Drug Revenue (2021-2032) & (US$ Million) Figure 16. Global IBS-C Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global IBS-C Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global IBS-C Drug Revenue Market Share by Region (2021-2032) Figure 19. Global IBS-C Drug Sales (2021-2032) & (K Units) Figure 20. Global IBS-C Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global IBS-C Drug Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico IBS-C Drug Sales YoY (2021-2032) & (K Units) Figure 23. Europe IBS-C Drug Sales YoY (2021-2032) & (K Units) Figure 24. China IBS-C Drug Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) IBS-C Drug Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa IBS-C Drug Sales YoY (2021-2032) & (K Units) Figure 27. Global IBS-C Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global IBS-C Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global IBS-C Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global IBS-C Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global IBS-C Drug Revenue Market Share by Type (2021-2032) Figure 33. Global IBS-C Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global IBS-C Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global IBS-C Drug Sales Market Share by Type (2021-2032) Figure 36. Global IBS-C Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global IBS-C Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global IBS-C Drug Revenue Market Share by Application (2021-2032) Figure 39. Global IBS-C Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global IBS-C Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global IBS-C Drug Sales Market Share by Application (2021-2032) Figure 42. North America IBS-C Drug Revenue Share by Type (2021-2032) Figure 43. North America IBS-C Drug Sales Share by Type (2021-2032) Figure 44. North America IBS-C Drug Revenue Share by Application (2021-2032) Figure 45. North America IBS-C Drug Sales Share by Application (2021-2032) Figure 46. North America IBS-C Drug Revenue Share by Country (2021-2032) Figure 47. North America IBS-C Drug Sales Share by Country (2021-2032) Figure 48. Europe IBS-C Drug Revenue Share by Type (2021-2032) Figure 49. Europe IBS-C Drug Sales Share by Type (2021-2032) Figure 50. Europe IBS-C Drug Revenue Share by Application (2021-2032) Figure 51. Europe IBS-C Drug Sales Share by Application (2021-2032) Figure 52. Europe IBS-C Drug Revenue Share by Country (2021-2032) Figure 53. Europe IBS-C Drug Sales Share by Country (2021-2032) Figure 54. China IBS-C Drug Revenue Share by Type (2021-2032) Figure 55. China IBS-C Drug Sales Share by Type (2021-2032) Figure 56. China IBS-C Drug Revenue Share by Application (2021-2032) Figure 57. China IBS-C Drug Sales Share by Application (2021-2032) Figure 58. Asia IBS-C Drug Revenue Share by Type (2021-2032) Figure 59. Asia IBS-C Drug Sales Share by Type (2021-2032) Figure 60. Asia IBS-C Drug Revenue Share by Application (2021-2032) Figure 61. Asia IBS-C Drug Sales Share by Application (2021-2032) Figure 62. Asia IBS-C Drug Revenue Share by Country (2021-2032) Figure 63. Asia IBS-C Drug Sales Share by Country (2021-2032) Figure 64. SAMEA IBS-C Drug Revenue Share by Type (2021-2032) Figure 65. SAMEA IBS-C Drug Sales Share by Type (2021-2032) Figure 66. SAMEA IBS-C Drug Revenue Share by Application (2021-2032) Figure 67. SAMEA IBS-C Drug Sales Share by Application (2021-2032) Figure 68. SAMEA IBS-C Drug Revenue Share by Country (2021-2032) Figure 69. SAMEA IBS-C Drug Sales Share by Country (2021-2032) Figure 70. IBS-C Drug Value Chain Figure 71. Manufacturing Cost Structure Figure 72. IBS-C Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • LINZESS (Linaclotide)
  • Amitiza
  • Milk of Magnesia
  • Lactulose
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Nestle
  • Synergy Pharmaceuticals
  • Catalent Pharmaceuticals Solutions
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 IBS-C Drug Market by Type
  3. 1.2.1 Global IBS-C Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 LINZESS (Linaclotide)
  5. 1.2.3 Amitiza
  6. 1.2.4 Milk of Magnesia
  7. 1.2.5 Lactulose
  8. 1.2.6 Others
  9. 1.3 IBS-C Drug Market by Application
  10. 1.3.1 Global IBS-C Drug Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Retail Pharmacies
  12. 1.3.3 Online Pharmacies
  13. 1.3.4 Hospital Pharmacies
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 IBS-C Drug Market Dynamics
  1. 2.1 IBS-C Drug Industry Trends
  2. 2.2 IBS-C Drug Industry Drivers
  3. 2.3 IBS-C Drug Industry Opportunities and Challenges
  4. 2.4 IBS-C Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global IBS-C Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global IBS-C Drug Revenue by Region
  3. 3.2.1 Global IBS-C Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global IBS-C Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global IBS-C Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global IBS-C Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global IBS-C Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global IBS-C Drug Sales by Region
  9. 3.4.1 Global IBS-C Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global IBS-C Drug Sales by Region (2021-2026)
  11. 3.4.3 Global IBS-C Drug Sales by Region (2027-2032)
  12. 3.4.4 Global IBS-C Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global IBS-C Drug Revenue by Manufacturers
  2. 4.1.1 Global IBS-C Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global IBS-C Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global IBS-C Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global IBS-C Drug Sales by Manufacturers
  6. 4.2.1 Global IBS-C Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global IBS-C Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global IBS-C Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global IBS-C Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global IBS-C Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global IBS-C Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global IBS-C Drug Manufacturers, Product Type & Application
  13. 4.7 Global IBS-C Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global IBS-C Drug Market CR5 and HHI
  16. 4.8.2 2025 IBS-C Drug Tier 1, Tier 2, and Tier 3
5 IBS-C Drug Market by Type
  1. 5.1 Global IBS-C Drug Revenue by Type
  2. 5.1.1 Global IBS-C Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global IBS-C Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global IBS-C Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global IBS-C Drug Sales by Type
  6. 5.2.1 Global IBS-C Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global IBS-C Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global IBS-C Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global IBS-C Drug Price by Type
6 IBS-C Drug Market by Application
  1. 6.1 Global IBS-C Drug Revenue by Application
  2. 6.1.1 Global IBS-C Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global IBS-C Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global IBS-C Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global IBS-C Drug Sales by Application
  6. 6.2.1 Global IBS-C Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global IBS-C Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global IBS-C Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global IBS-C Drug Price by Application
7 Company Profiles
  1. 7.1 Nestle
  2. 7.1.1 Nestle Company Information
  3. 7.1.2 Nestle Business Overview
  4. 7.1.3 Nestle IBS-C Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Nestle IBS-C Drug Product Portfolio
  6. 7.1.5 Nestle Recent Developments
  7. 7.2 Synergy Pharmaceuticals
  8. 7.2.1 Synergy Pharmaceuticals Company Information
  9. 7.2.2 Synergy Pharmaceuticals Business Overview
  10. 7.2.3 Synergy Pharmaceuticals IBS-C Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Synergy Pharmaceuticals IBS-C Drug Product Portfolio
  12. 7.2.5 Synergy Pharmaceuticals Recent Developments
  13. 7.3 Catalent Pharmaceuticals Solutions
  14. 7.3.1 Catalent Pharmaceuticals Solutions Company Information
  15. 7.3.2 Catalent Pharmaceuticals Solutions Business Overview
  16. 7.3.3 Catalent Pharmaceuticals Solutions IBS-C Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Catalent Pharmaceuticals Solutions IBS-C Drug Product Portfolio
  18. 7.3.5 Catalent Pharmaceuticals Solutions Recent Developments
  19. 7.4 Abbott Laboratories
  20. 7.4.1 Abbott Laboratories Company Information
  21. 7.4.2 Abbott Laboratories Business Overview
  22. 7.4.3 Abbott Laboratories IBS-C Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Abbott Laboratories IBS-C Drug Product Portfolio
  24. 7.4.5 Abbott Laboratories Recent Developments
8 North America
  1. 8.1 North America IBS-C Drug Market Size by Type
  2. 8.1.1 North America IBS-C Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America IBS-C Drug Sales by Type (2021-2032)
  4. 8.1.3 North America IBS-C Drug Price by Type (2021-2032)
  5. 8.2 North America IBS-C Drug Market Size by Application
  6. 8.2.1 North America IBS-C Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America IBS-C Drug Sales by Application (2021-2032)
  8. 8.2.3 North America IBS-C Drug Price by Application (2021-2032)
  9. 8.3 North America IBS-C Drug Market Size by Country
  10. 8.3.1 North America IBS-C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America IBS-C Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America IBS-C Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe IBS-C Drug Market Size by Type
  2. 9.1.1 Europe IBS-C Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe IBS-C Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe IBS-C Drug Price by Type (2021-2032)
  5. 9.2 Europe IBS-C Drug Market Size by Application
  6. 9.2.1 Europe IBS-C Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe IBS-C Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe IBS-C Drug Price by Application (2021-2032)
  9. 9.3 Europe IBS-C Drug Market Size by Country
  10. 9.3.1 Europe IBS-C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe IBS-C Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe IBS-C Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China IBS-C Drug Market Size by Type
  2. 10.1.1 China IBS-C Drug Revenue by Type (2021-2032)
  3. 10.1.2 China IBS-C Drug Sales by Type (2021-2032)
  4. 10.1.3 China IBS-C Drug Price by Type (2021-2032)
  5. 10.2 China IBS-C Drug Market Size by Application
  6. 10.2.1 China IBS-C Drug Revenue by Application (2021-2032)
  7. 10.2.2 China IBS-C Drug Sales by Application (2021-2032)
  8. 10.2.3 China IBS-C Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia IBS-C Drug Market Size by Type
  2. 11.1.1 Asia IBS-C Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia IBS-C Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia IBS-C Drug Price by Type (2021-2032)
  5. 11.2 Asia IBS-C Drug Market Size by Application
  6. 11.2.1 Asia IBS-C Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia IBS-C Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia IBS-C Drug Price by Application (2021-2032)
  9. 11.3 Asia IBS-C Drug Market Size by Country
  10. 11.3.1 Asia IBS-C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia IBS-C Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia IBS-C Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA IBS-C Drug Market Size by Type
  2. 12.1.1 SAMEA IBS-C Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA IBS-C Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA IBS-C Drug Price by Type (2021-2032)
  5. 12.2 SAMEA IBS-C Drug Market Size by Application
  6. 12.2.1 SAMEA IBS-C Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA IBS-C Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA IBS-C Drug Price by Application (2021-2032)
  9. 12.3 SAMEA IBS-C Drug Market Size by Country
  10. 12.3.1 SAMEA IBS-C Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA IBS-C Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA IBS-C Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 IBS-C Drug Value Chain Analysis
  2. 13.1.1 IBS-C Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 IBS-C Drug Production Mode & Process
  6. 13.2 IBS-C Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 IBS-C Drug Distributors
  9. 13.2.3 IBS-C Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst